Biotech Values

[mcbio]

BMY issued 2011 non-GAAP EPS guidance of $2.10-2.20 (2.00-2.10 GAAP):

finance.yahoo.com/news/BristolMyers-Squibb-Delivers-bw-3110410876.html?x=0&.v=1

BMY reiterated 2013 (first year post-Plavix) non-GAAP EPS guidance of $1.95+ that was first given in Mar 2010 (#msg-47502391). There is no official guidance for 2012.

Did you, or others, by chance listen to BMY's 4Q10 CC? Just curious if the collaboration with VRUS came up at any point during planned remarks or Q&A and if there was anything of note.